Immunocore Holdings plc (NASDAQ:IMCR) Financial Performance and Competitive Analysis
Immunocore(US:IMCR) Financial Modeling Prep·2025-12-21 02:00Immunocore Holdings plc (NASDAQ:IMCR) has a Return on Invested Capital (ROIC) of -4.49%, indicating challenges in generating returns above its cost of capital.Compared to its peers, IMCR's ROIC to WACC ratio of -0.68 suggests better capital efficiency, albeit still below the desired threshold.Design Therapeutics, Inc. (DSGN) shows the highest ROIC to WACC ratio among the peers, but IMCR maintains a relatively strong position with potential for improvement in capital utilization.Immunocore Holdings plc (NASD ...